US Stock MarketDetailed Quotes
ADPT Adaptive Biotechnologies
- 5.080
- -0.500-8.96%
Close Nov 15 16:00 ET
- 5.190
- +0.110+2.17%
Post 20:01 ET
749.70MMarket Cap-3791P/E (TTM)
5.788High5.070Low1.46MVolume5.630Open5.580Pre Close7.68MTurnover1.90%Turnover RatioLossP/E (Static)147.58MShares6.70052wk High3.35P/B390.16MFloat Cap2.28052wk Low--Dividend TTM76.80MShs Float71.250Historical High--Div YieldTTM12.87%Amplitude2.280Historical Low5.251Avg Price1Lot Size
Adaptive Biotechnologies Key Stats
EPS
According to the latest financial report of Adaptive Biotechnologies, the latest earnings per share (TTM) for the company is -0.22. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Adaptive Biotechnologies's free cash flow? The latest report shows it as -27.41M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Adaptive Biotechnologies shows that the company's current ratio is 3.52, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Adaptive Biotechnologies, the quick ratio is 3.24, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Adaptive Biotechnologies? The latest ROE figure is -13.78%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Adaptive Biotechnologies, the total asset return on investment (ROA) is -5.61%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Adaptive Biotechnologies's latest financial report to see how their gross margin is doing - currently at 64.11%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Adaptive Biotechnologies, the net profit margin is -69.12%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data